BR112013001492A2 - combinação de siloxano e ingrediente ativo para tratar doença dentária. - Google Patents
combinação de siloxano e ingrediente ativo para tratar doença dentária.Info
- Publication number
- BR112013001492A2 BR112013001492A2 BR112013001492A BR112013001492A BR112013001492A2 BR 112013001492 A2 BR112013001492 A2 BR 112013001492A2 BR 112013001492 A BR112013001492 A BR 112013001492A BR 112013001492 A BR112013001492 A BR 112013001492A BR 112013001492 A2 BR112013001492 A2 BR 112013001492A2
- Authority
- BR
- Brazil
- Prior art keywords
- active ingredient
- siloxane
- combination
- dental disease
- treat dental
- Prior art date
Links
- 208000018035 Dental disease Diseases 0.000 title abstract 3
- 208000014151 Stomatognathic disease Diseases 0.000 title abstract 3
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 title abstract 3
- 239000004480 active ingredient Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002831 pharmacologic agent Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/50—Preparations specially adapted for dental root treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
- A61K6/69—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Dental Preparations (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10007536A EP2409702A1 (en) | 2010-07-21 | 2010-07-21 | Combination of siloxane and active ingredient for treating dental disorder of hard tissues |
| PCT/EP2011/061953 WO2012010478A1 (en) | 2010-07-21 | 2011-07-13 | Combination of siloxane and active ingredient for treating dental disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013001492A2 true BR112013001492A2 (pt) | 2016-05-31 |
Family
ID=43038027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013001492A BR112013001492A2 (pt) | 2010-07-21 | 2011-07-13 | combinação de siloxano e ingrediente ativo para tratar doença dentária. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20130184239A1 (https=) |
| EP (2) | EP2409702A1 (https=) |
| JP (1) | JP2013531048A (https=) |
| KR (1) | KR20130043203A (https=) |
| CN (1) | CN103096890A (https=) |
| AU (1) | AU2011281719A1 (https=) |
| BR (1) | BR112013001492A2 (https=) |
| CA (1) | CA2805980A1 (https=) |
| MX (1) | MX2013000800A (https=) |
| RU (1) | RU2013107451A (https=) |
| WO (1) | WO2012010478A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2699371C1 (ru) * | 2018-12-06 | 2019-09-05 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КубГМУ Минздрава России) | Стоматологическая паста для временного пломбирования каналов корней зубов при лечении хронического деструктивного периодонтита |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11180841A (ja) * | 1997-12-15 | 1999-07-06 | Lion Corp | 口腔用組成物 |
| DE19962470A1 (de) * | 1999-12-22 | 2001-07-12 | Schulz Hans Herrmann | Verwendung von Chemotherapeutika |
| JP2001354535A (ja) * | 2000-06-13 | 2001-12-25 | Lion Corp | 口腔用組成物 |
| JP2002179569A (ja) | 2000-12-12 | 2002-06-26 | Lion Corp | 口腔用組成物 |
| EP1472263B1 (de) | 2001-11-13 | 2006-08-30 | GE Bayer Silicones GmbH & Co. KG | Verwendung von siloxanen als verdampfbare träger |
| EP1443892B1 (en) | 2001-11-15 | 2009-06-10 | Laboratorios Miret, S.A. | Use of cationic surfactant as antimicrobial activity enhancer in deodorants and oral care |
| JP2004107310A (ja) * | 2002-09-13 | 2004-04-08 | Lion Corp | 口腔用組成物 |
| WO2007013175A1 (ja) | 2005-07-29 | 2007-02-01 | Takeshi Tanaka | 歯用漂白剤 |
| GB0518769D0 (en) | 2005-09-14 | 2005-10-19 | Medpharm Ltd | Topical formulations |
-
2010
- 2010-07-21 EP EP10007536A patent/EP2409702A1/en not_active Withdrawn
-
2011
- 2011-07-13 KR KR1020137004211A patent/KR20130043203A/ko not_active Withdrawn
- 2011-07-13 RU RU2013107451/04A patent/RU2013107451A/ru not_active Application Discontinuation
- 2011-07-13 CN CN2011800454969A patent/CN103096890A/zh active Pending
- 2011-07-13 MX MX2013000800A patent/MX2013000800A/es not_active Application Discontinuation
- 2011-07-13 US US13/811,140 patent/US20130184239A1/en not_active Abandoned
- 2011-07-13 AU AU2011281719A patent/AU2011281719A1/en not_active Abandoned
- 2011-07-13 BR BR112013001492A patent/BR112013001492A2/pt not_active IP Right Cessation
- 2011-07-13 EP EP11730703.3A patent/EP2595626A1/en not_active Withdrawn
- 2011-07-13 WO PCT/EP2011/061953 patent/WO2012010478A1/en not_active Ceased
- 2011-07-13 JP JP2013520068A patent/JP2013531048A/ja active Pending
- 2011-07-13 CA CA2805980A patent/CA2805980A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2409702A1 (en) | 2012-01-25 |
| CN103096890A (zh) | 2013-05-08 |
| US20130184239A1 (en) | 2013-07-18 |
| KR20130043203A (ko) | 2013-04-29 |
| JP2013531048A (ja) | 2013-08-01 |
| CA2805980A1 (en) | 2012-01-26 |
| RU2013107451A (ru) | 2014-08-27 |
| AU2011281719A1 (en) | 2013-02-21 |
| MX2013000800A (es) | 2013-02-27 |
| EP2595626A1 (en) | 2013-05-29 |
| WO2012010478A1 (en) | 2012-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119474T1 (el) | Κρυσταλλικες μορφες 5-χλωρο-ν2-(2-ισοπροποξυ-5-μεθυλ-4-πιπεριδιν-4-υλ-φαινυλ)-ν4[2-(προπανο-2-σουλφονυλ)-φαινυλ]-πυριμιδιν-2,4-διαμινης | |
| EA201490228A1 (ru) | Новые производные трифторметилоксадиазола и их применение для лечения заболевания | |
| BR112015003188A2 (pt) | Composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
| EA201491060A1 (ru) | Новые производные трифторметилоксадиазола и их применение для лечения заболевания | |
| UA111588C2 (uk) | Композиція інгібітора jak для місцевого застосування | |
| CO6690805A2 (es) | 6-amino-nicotinamidas sustituidas como modulares de kcnq2/3 | |
| MD4754B1 (ro) | Compuşi policiclici de carbamoilpiridonă şi utilizarea lor farmaceutică | |
| BR112014023384A8 (pt) | inibidores de bace espirocíclicos de di-hidro-tiazina e di-hidro-oxazina, e composições e usos dos mesmos. | |
| DOP2014000008A (es) | 4-imidazopiridazina-1-il-benzamidas y 4-imidazotriazina-1-il-benzamidas como inhibidores de btk | |
| SV2011003802A (es) | Derivados de triazol utiles para el tratamiento de enfermedades | |
| GB2511685A (en) | Muscarinic m1 receptor agonists | |
| AR084932A1 (es) | Composicion oftalmica que comprende un androgeno y su uso para la fabricacion de un medicamento util para el tratamiento de una enfermedad ocular resultante de una deficiencia androgenica | |
| CU20140068A7 (es) | Triazolopiridinas sustituidas | |
| CU20120171A7 (es) | Triazolopiridinas sustituidas | |
| TW200806300A (en) | New therapeutic combinations for the treatment of depression | |
| MX2013003635A (es) | Compuestos de n-heteroarilo. | |
| UA110013C2 (uk) | Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів | |
| CA2878796C (en) | Derivatives of pyridinone as inhibitors for tissue transglutaminase | |
| BR102013003570A8 (pt) | Composições de plasma rico em plaquetas | |
| MX389600B (es) | Nueva composición terapéutica que contiene ingrediente activo de apomorfinas. | |
| MX2023014492A (es) | Compuestos utiles en la terapia para el vih. | |
| AR077139A1 (es) | Composiciones farmaceuticas utiles para tratar el vch | |
| CY1116234T1 (el) | Υποκατεστημενα 2-οξυ-κινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3 | |
| EA201500375A1 (ru) | Композиция для ухода за ротовой полостью | |
| MA32841B1 (fr) | Composés de cycloundeca depsipeptides et leur utilisation comme médicament |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2383 DE 06-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |